John M Luk

Summary

Affiliation: National University of Singapore
Country: Singapore

Publications

  1. ncbi A protein-based set of reference markers for liver tissues and hepatocellular carcinoma
    Stella Sun
    Department of Surgery, LKS Faculty of Medicine, Jockey Club Clinical Research Centre, The University of Hong Kong, Pokfulam, Hong Kong
    BMC Cancer 9:309. 2009
  2. ncbi Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
    Ke Hao
    1Rosetta Inpharmatics LLC, Merck Research Laboratories, Seattle, WA, USA
    BMC Cancer 9:389. 2009
  3. ncbi Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker
    Lei Chen
    Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Ann Surg Oncol 17:2518-25. 2010
  4. ncbi DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival
    John M Luk
    Cancer Science Institute and Department of Pharmacology, National University of Singapore, 117597, Singapore
    J Biol Chem 286:30706-13. 2011
  5. ncbi Proteomics of hepatocellular carcinoma in Chinese patients
    John M Luk
    Department of Pharmacology, Cancer Science Institute, National University of Singapore, Singapore
    OMICS 15:261-6. 2011
  6. ncbi Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma
    Angela M Liu
    Department of Pharmacology, Cancer Science Institute, National University of Singapore, Singapore
    OMICS 15:187-91. 2011
  7. ncbi Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma
    Kwong Fai Wong
    Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
    Methods Mol Biol 909:295-310. 2012
  8. ncbi Regulators of mammalian Hippo pathway in cancer
    Angela M Liu
    Department of Pharmacology, National University of Singapore, Singapore
    Biochim Biophys Acta 1826:357-64. 2012
  9. ncbi Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
    Dong xing Cao
    Dong Xing Cao, Zhi Jie Li, Xiao Ou Jiang, Yick Liang Lum, Ester Khin, John M Luk, Department of Pharmacology and Department of Surgery, National University Health System, National University of Singapore, Singapore 117597, Singapore
    World J Gastroenterol 18:3923-30. 2012
  10. ncbi Targeting YAP and Hippo signaling pathway in liver cancer
    Angela M Liu
    Department of Pharmacology, National University of Singapore, 117597, Singapore
    Expert Opin Ther Targets 14:855-68. 2010

Collaborators

  • Nikki P Lee
  • Daniel G Tenen
  • Peramaiyan Rajendran
  • Wei Wang
  • Irena Ivanovska
  • Kwong Fai Wong
  • Angela M Liu
  • Ronnie T Poon
  • Stella Sun
  • Dong xing Cao
  • Hongyue Dai
  • Chunsheng Zhang
  • Lei Chen
  • Ronnie T P Poon
  • Xin Yi
  • Ke Hao
  • Zhi Jie Li
  • Ester Khin
  • Yi Yuan
  • Yiting Qiao
  • Guo Hao Wu
  • Xiao Ou Jiang
  • Xiaoou Jiang
  • Yick Liang Lum
  • Zhi Xu
  • Julja Burchard
  • S T Fan
  • Jinfei Chen
  • Zongwei Cai
  • Jirun Peng
  • Xisheng Leng
  • Terence C W Poon
  • David Ho
  • Michelle Z Xu
  • Eddy W Y Ng
  • George K Lau
  • Jose M Casasnovas
  • Paul B S Lai
  • David W Y Ho
  • Brian Lam
  • Jana Wo
  • Irene O Ng
  • Philip J R Day
  • John Lamb
  • Mao Mao
  • Chun Yeung
  • Pak C Sham
  • Ronnie Tp Poon
  • Mark D Ferguson

Detail Information

Publications14

  1. ncbi A protein-based set of reference markers for liver tissues and hepatocellular carcinoma
    Stella Sun
    Department of Surgery, LKS Faculty of Medicine, Jockey Club Clinical Research Centre, The University of Hong Kong, Pokfulam, Hong Kong
    BMC Cancer 9:309. 2009
    ..This is the first study employed 2-DE analysis to screen for potential reference markers and aims to correlate the abundance of these proteins with their level of transcript expression...
  2. ncbi Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
    Ke Hao
    1Rosetta Inpharmatics LLC, Merck Research Laboratories, Seattle, WA, USA
    BMC Cancer 9:389. 2009
    ..However, the results are not consistent due to lack of systemic approach to establish a prediction model incorporating all these parameters...
  3. ncbi Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker
    Lei Chen
    Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
    Ann Surg Oncol 17:2518-25. 2010
    ..We applied SELDI-TOF-MS ProteinChip technology to identify serum profile for distinguishing HCC and liver cirrhosis (LC) and to compare the accuracy of SELDI-TOF-MS profile and alpha-fetoprotein (AFP) level in HCC diagnosis...
  4. ncbi DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival
    John M Luk
    Cancer Science Institute and Department of Pharmacology, National University of Singapore, 117597, Singapore
    J Biol Chem 286:30706-13. 2011
    ..In conclusion, our findings suggest that coordinate up-regulation of the DLK1-DIO3 miRNA cluster at 14q32.2 may define a novel molecular (stem cell-like) subtype of HCC associated with poor prognosis...
  5. ncbi Proteomics of hepatocellular carcinoma in Chinese patients
    John M Luk
    Department of Pharmacology, Cancer Science Institute, National University of Singapore, Singapore
    OMICS 15:261-6. 2011
    ....
  6. ncbi Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma
    Angela M Liu
    Department of Pharmacology, Cancer Science Institute, National University of Singapore, Singapore
    OMICS 15:187-91. 2011
    ..This study provides molecular clues that may contribute to the global changes of miRNA expression in HCC...
  7. ncbi Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma
    Kwong Fai Wong
    Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
    Methods Mol Biol 909:295-310. 2012
    ..Focus is emphasized on the methods for sample preservation and low-abundance protein enrichment...
  8. ncbi Regulators of mammalian Hippo pathway in cancer
    Angela M Liu
    Department of Pharmacology, National University of Singapore, Singapore
    Biochim Biophys Acta 1826:357-64. 2012
    ..Understanding of the mammalian Hippo pathway regulation may shed new insights to allow us selecting the right oncogenic targets and designing effective drugs for cancer treatments...
  9. ncbi Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
    Dong xing Cao
    Dong Xing Cao, Zhi Jie Li, Xiao Ou Jiang, Yick Liang Lum, Ester Khin, John M Luk, Department of Pharmacology and Department of Surgery, National University Health System, National University of Singapore, Singapore 117597, Singapore
    World J Gastroenterol 18:3923-30. 2012
    ..Better understanding of the implications of OPN in tumorigenesis might facilitate development of therapeutic regimens to benefit patients with these deadly malignancies...
  10. ncbi Targeting YAP and Hippo signaling pathway in liver cancer
    Angela M Liu
    Department of Pharmacology, National University of Singapore, 117597, Singapore
    Expert Opin Ther Targets 14:855-68. 2010
    ..Recently, YAP has been implicated as a bona fide oncogene in solid tumors, but little is known about its exact molecular mechanism in carcinogenesis...
  11. ncbi Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo
    Peramaiyan Rajendran
    Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore
    Cancer Prev Res (Phila) 5:631-43. 2012
    ..Overall, our results suggest for the first time that celastrol exerts its antiproliferative and proapoptotic effects through suppression of STAT3 signaling in HCC both in vitro and in vivo...
  12. ncbi Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents
    Kwong Fai Wong
    Cancer Science Institute of SingaporeDepartments of PharmacologySurgery, National University Health System, National University of Singapore, Singapore
    Clin Exp Pharmacol Physiol 39:311-20. 2012
    ..5. Triptolide derivatives with improved water solubility have emerged as promising drug candidates. Clinical trials are being conducted on the derivatives to provide encyclopaedic knowledge on triptolide pharmacokinetics in patients...
  13. ncbi An update on targeting Hippo-YAP signaling in liver cancer
    Angela M Liu
    Department of Oncology, Nanjing Medical University, Nanjing, China
    Expert Opin Ther Targets 16:243-7. 2012
    ..This knowledge provides a basis for rational design of therapeutics against cancer that depends upon Hippo-YAP signaling for growth...
  14. ncbi Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model
    Kwong Fai Wong
    Department of Pharmacology and Surgery, National University Hospital System, National University of Singapore, Singapore 117597, Singapore
    World J Gastroenterol 16:2648-56. 2010
    ..To evaluate the prophylactic properties of integrin CD18-betaA peptide in a murine model of abdominal polymicrobial peritonitis and sepsis...